190 related articles for article (PubMed ID: 31006821)
1. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Pfeiffer RM; Gadalla SM; Swain SM; Merajver SD; Brown LM; Soliman AS
Breast Cancer Res Treat; 2019 Jul; 176(2):407-417. PubMed ID: 31006821
[TBL] [Abstract][Full Text] [Related]
2. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.
Schairer C; Soliman AS; Omar S; Khaled H; Eissa S; Ayed FB; Khalafallah S; Ayoub WB; Kantor ED; Merajver S; Swain SM; Gail M; Brown LM
Cancer Med; 2013 Apr; 2(2):178-84. PubMed ID: 23634285
[TBL] [Abstract][Full Text] [Related]
3. Imaging Modalities in Inflammatory Breast Cancer (IBC) Diagnosis: A Computer-Aided Diagnosis System Using Bilateral Mammography Images.
Barkana BD; El-Sayed A; Khaled RH; Helal M; Khaled H; Deeb R; Pitcher M; Pfeiffer R; Roubidoux M; Schairer C; Soliman AS
Sensors (Basel); 2022 Dec; 23(1):. PubMed ID: 36616659
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.
Soliman AS; Kleer CG; Mrad K; Karkouri M; Omar S; Khaled HM; Benider AL; Ayed FB; Eissa SS; Eissa MS; McSpadden EJ; Lo AC; Toy K; Kantor ED; Xiao Q; Hampton C; Merajver SD
Breast Dis; 2011-2012; 33(4):159-69. PubMed ID: 23001584
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Bastawisy AE; Yehia M; Gadalla SM; Swain SM; Merajver SD; Brown LM; Pfeiffer RM; Soliman AS
Breast Cancer Res Treat; 2020 Nov; 184(2):543-558. PubMed ID: 32876910
[TBL] [Abstract][Full Text] [Related]
6. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Bertucci F; Rypens C; Finetti P; Guille A; Adélaïde J; Monneur A; Carbuccia N; Garnier S; Dirix P; Gonçalves A; Vermeulen P; Debeb BG; Wang X; Dirix L; Ueno NT; Viens P; Cristofanilli M; Chaffanet M; Birnbaum D; Van Laere S
Mol Oncol; 2020 Mar; 14(3):504-519. PubMed ID: 31854063
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast cancer: a single centre analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
[TBL] [Abstract][Full Text] [Related]
10. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
11. Reliability of medical records in diagnosing inflammatory breast cancer in Egypt.
Le L; Schairer C; Hablas A; Meza J; Watanabe-Galloway S; Ramadan M; Merajver SD; Seifeldin IA; Soliman AS
BMC Res Notes; 2017 Mar; 10(1):126. PubMed ID: 28302157
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological risk factors associated with inflammatory breast cancer subtypes.
Atkinson RL; El-Zein R; Valero V; Lucci A; Bevers TB; Fouad T; Liao W; Ueno NT; Woodward WA; Brewster AM
Cancer Causes Control; 2016 Mar; 27(3):359-66. PubMed ID: 26797453
[TBL] [Abstract][Full Text] [Related]
14. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
[TBL] [Abstract][Full Text] [Related]
15. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Dawood S; Merajver SD; Viens P; Vermeulen PB; Swain SM; Buchholz TA; Dirix LY; Levine PH; Lucci A; Krishnamurthy S; Robertson FM; Woodward WA; Yang WT; Ueno NT; Cristofanilli M
Ann Oncol; 2011 Mar; 22(3):515-523. PubMed ID: 20603440
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
17. Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study.
Mejri N; El Benna H; Rachdi H; Labidi S; Benna M; Daoud N; Hamdi Y; Abdelhak S; Boussen H
Oncol Res Treat; 2020; 43(5):204-210. PubMed ID: 32203954
[TBL] [Abstract][Full Text] [Related]
18. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for inflammatory breast cancer and other invasive breast cancers.
Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
[TBL] [Abstract][Full Text] [Related]
20. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]